ADAMTS13 and Thrombocytopenia: Some studies have identified that a subgroup of SLE-associated TMA patients with acquired ADAMTS13 deficiency had a relatively benign outcome, even though these patients presented with extreme thrombocytopenia and CNS symptoms [20,21].